ATE238297T1 - Chinolinderivat - Google Patents

Chinolinderivat

Info

Publication number
ATE238297T1
ATE238297T1 AT95934864T AT95934864T ATE238297T1 AT E238297 T1 ATE238297 T1 AT E238297T1 AT 95934864 T AT95934864 T AT 95934864T AT 95934864 T AT95934864 T AT 95934864T AT E238297 T1 ATE238297 T1 AT E238297T1
Authority
AT
Austria
Prior art keywords
carbon atoms
group
integer
phenyl
alkyl
Prior art date
Application number
AT95934864T
Other languages
English (en)
Inventor
Yutaka Nomura
Shogo Sakuma
Seiichiro Masui
Original Assignee
Nippon Chemiphar Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co filed Critical Nippon Chemiphar Co
Application granted granted Critical
Publication of ATE238297T1 publication Critical patent/ATE238297T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95934864T 1994-10-20 1995-10-20 Chinolinderivat ATE238297T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP28130194 1994-10-20
JP21805695 1995-08-03
PCT/JP1995/002167 WO1996012719A1 (fr) 1994-10-20 1995-10-20 Derive de quinoline

Publications (1)

Publication Number Publication Date
ATE238297T1 true ATE238297T1 (de) 2003-05-15

Family

ID=26522365

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95934864T ATE238297T1 (de) 1994-10-20 1995-10-20 Chinolinderivat

Country Status (10)

Country Link
US (1) US5693651A (de)
EP (1) EP0787725B1 (de)
KR (1) KR100356551B1 (de)
CN (1) CN1071333C (de)
AT (1) ATE238297T1 (de)
AU (1) AU712802B2 (de)
CA (1) CA2201113A1 (de)
DE (1) DE69530501D1 (de)
RU (1) RU2137770C1 (de)
WO (1) WO1996012719A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020871A1 (fr) * 1996-11-08 1998-05-22 Nippon Chemiphar Co., Ltd. Agent diminuant la graisse viscerale
WO2000073273A1 (fr) * 1999-05-28 2000-12-07 Nippon Chemiphar Co., Ltd. Procede d'obtention de derives 2-halo-3-(3-quinolyl) acide proprionique
WO2002051441A1 (fr) * 2000-12-26 2002-07-04 Sankyo Company, Limited Compositions medicinales contenant un diuretique et un agent renforçant la resistance a l'insuline
US7015345B2 (en) * 2002-02-21 2006-03-21 Asahi Kasei Pharma Corporation Propionic acid derivatives
US20050119314A1 (en) * 2002-04-05 2005-06-02 Sankyo Company, Limited Pharmaceutical composition comprising an ACAT inhibitor and an insulin resistance reducing agent
US7232828B2 (en) 2002-08-10 2007-06-19 Bethesda Pharmaceuticals, Inc. PPAR Ligands that do not cause fluid retention, edema or congestive heart failure
PA8594401A1 (es) * 2003-02-21 2004-09-16 Pfizer Acidos carboxilicos de heteroarilo condensado como agonista del ppar
WO2008020302A2 (en) * 2006-08-17 2008-02-21 Pfizer Products Inc. Heteroaromatic quinoline-based compounds as phosphodiesterase (pde) inhibitors
WO2008066558A2 (en) * 2006-11-30 2008-06-05 Dow Agrosciences Llc Process for the preparation of 2-substituted-5-(1-alkylthio)alkylpyridines
CN102884062B (zh) 2009-12-23 2016-08-03 嘉世高制药公司 氨基嘧啶激酶抑制剂
CA2832865C (en) 2011-04-22 2021-05-11 Jasco Pharmaceuticals, LLC Aminopyrimidine kinase inhibitors
BR112014010563B1 (pt) 2011-11-04 2021-01-12 Jasco Pharmaceuticals, LLC compostos inibidores da aminopirimidina quinase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
ZA936492B (en) * 1992-09-10 1995-03-02 Lilly Co Eli Compounds useful as hypoglycemic agents and for treating Alzheimer's disease.
FR2696743B1 (fr) * 1992-10-12 1994-12-23 Adir Nouveaux composés de thiazolidine dione, leur procédé de préparation et les compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
AU3709895A (en) 1996-05-15
AU712802B2 (en) 1999-11-18
CN1071333C (zh) 2001-09-19
EP0787725A4 (de) 1998-01-07
CN1170411A (zh) 1998-01-14
CA2201113A1 (en) 1996-05-02
US5693651A (en) 1997-12-02
WO1996012719A1 (fr) 1996-05-02
EP0787725B1 (de) 2003-04-23
KR970707122A (ko) 1997-12-01
EP0787725A1 (de) 1997-08-06
KR100356551B1 (ko) 2002-12-18
RU2137770C1 (ru) 1999-09-20
DE69530501D1 (de) 2003-05-28

Similar Documents

Publication Publication Date Title
DE69918404D1 (de) Aminophenoxyessigsäure derivate als neuroschützende mittel
FR2805810B1 (fr) Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation
PT1022272E (pt) Compostos heterociclicos fundidos substituidos
ATE238297T1 (de) Chinolinderivat
EP1394154A4 (de) Fünfgliedriges heterocyclisches alkansäurederivat
DK616388D0 (da) Quinolincarboxylsyre-derivater og fysiologisk acceptable salte deraf med antibakteriel virkning
ES8506629A1 (es) Un procedimiento para preparar derivados de piridina
ID24846A (id) Turunan-turunan bifenilamidina
DE68911371D1 (de) 2,2-Disubstituierte Benzopyran-Leukotrien-D4-Antagonisten.
ES2106439T3 (es) 5-(piperazinilalquil)-1,5-benzotiazepinonas utiles como antagonistas de calcio.
EA200300010A1 (ru) Производные 2-аминотиазолина и их применение в качестве ингибиторов no-синтазы
DE68918832T2 (de) Benzoxazepinderivate.
FR2769913B1 (fr) Nouveaux derives cyclohexaniques difonctionnalises en 1, 4, leur preparation et leur application therapeutique humaine
HUP0301561A2 (hu) Triazintrion-szulfoxidok alkalmazása kokcidiózis elleni készítmények elżállítására
NO20002967L (no) Uretaner avledet fra azacycloalkaner, tio og ditio-analoger, samt anvendelse og fremstilling av 2,3 eposkysqualen- lanesterolcyclaseinhibitor
AU532634B2 (en) Thiazolyl derivatives
DE69124017D1 (de) Heterocyclische Derivate
NO20021162L (no) 5-aminoalkyl og 5-aminokarbonyl-substituerte indoler
EA200300009A1 (ru) Производные 4,5-дигидротиазол-2-иламина и их применение в качестве ингибиторов no синтазы
EA200200462A1 (ru) Производные 2-арилхинолина, их получение и терапевтическое применение
FR2629456B1 (fr) Derives des acides 7-(1-imidazolyl),1,4-dihydro-4-oxo-6,8-difluoro-1-cyclopropyl-3-quinoleincarboxylique, leur preparation et leur application en tant que medicaments

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties